Search
Filter Results
Displaying 491–500 of 955 results
-
Jul 22, 2020
Accepting grant applications for advancing retinal degeneration treatments toward human studies
-
Jul 17, 2020
A Phase 3 trial for the treatment is planned
-
Bronze Partner - Janssen Pharmaceutical Companies
Bronze Partner - Janssen Pharmaceutical Companies
-
Gold Partner and Accessibility Underwriter - Spark Therapeutics
Gold Partner & Accessibility Underwriter Spark Therapeutics
-
National Chapter Vision Webinars
Bimonthly national Vision Webinars providing key information impacting our community.
-
Jul 7, 2020
Biogen Entering into Licensing Agreement with Mass Eye and Ear to Develop PRPF31 Gene Therapy
The goal of the partnership is to advance a PRPF31 gene therapy into a clinical trial
-
Translational Research Acceleration Program (TRAP) Award
The Translational Research Acceleration Program (TRAP) awards will accelerate the movement of preclinical research toward an Investigational New Drug filing and into clinical trials to provide a robust and diverse pipeline of potential therapies to fight inherited retinal degenerations (IRD) and dry age-related macular degeneration.